CD37 抗体
Our Local Distributor
北京 101111
Quick Overview for CD37 抗体 (ABIN7865743)
抗原
See all CD37 (TSPAN26) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- anti-CD37 mouse monoclonal, IPO-24, purified
-
纯化方法
- affinity chromatography
-
免疫原
- spleen cells of a patient with hairy cell leukemia
-
亚型
- IgG2b kappa
-
-
-
-
应用备注
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 100 μg/mL
-
缓冲液
- PBS with 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- store at 2 - 8 °C
-
-
- CD37 (TSPAN26) (Tetraspanin 26 (TSPAN26))
-
别名
- CD37
-
背景
- IPO-24 reacts with CD37, a B lineage restricted antigen, strongly expressed throughout B-cell ontogeny from pre B-cell until plasmablasts. Plasma cells are negative. IPO-24 reacts with human B-cell lines Daudi, Raji, Namalva, Ramos and CABIL, whereas T-cell lines CEM, Molt-4, Jurkat, MT-4, H9 and non-lymphoid cell lines MeWo and A-431 are negative. IPO-24 stains B-cell follicles and the most strongly labelled elements are mantle zone lymphoid cells. Neutrophils, macrophages, thymocytes and dendritic reticulum cells are negative. Positive control: Daudi, Raji, Namalva and CABIL cells, human tonsil or lymph node.
-
途径
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
抗原
-